Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 48 for “"CD13"”.
-
The impact of CD13 on glioma progression
Background: CD13, an aminopeptidase, has been identified as a potential therapeutic target in various cancers. However, its role in gliomas remains largely unexplored. This study aimed to investigate CD13 expression in glioblastoma patients. Furthermore, dif ferent glioma cell lines were analyzed …
-
Developing a Rational Peptide Ligand Design Method Using CD13 as a Prototype Target Receptor
… Specific peptide ligands for the model receptor CD13 that are overexpressed in several cancer types were designed in this study. From the initial library of designed peptides, three potential candidates were selected based on simulated energies in the CD13 binding site using the programs …
-
Pacientų, kuriems įtariama ūminė promielocitinė leukemija, blastų biožymenų raiškos ypatumai /
… SSC-h / CD34- / CD117 + b / CD33 ++ / CD13 + h / CD2- / CD56- / CD64 + / CD15 + b / HLA-DR-; SSC-h / CD34- / CD117 + b / CD33 ++ / CD13 ++ / CD2- / CD56- / CD64 + / CD15 + b / HLA-DR-; SSC-h / CD34- / CD117 + / CD33 + / CD13 + / CD2 + b / CD56- / CD64 + b / CD15 + b / HLA-DR-; SSC-H / …
-
RESIDUAL DORMANT CANCER STEM CELL FOCI ARE RESPONSIBLE FOR TUMOR RELAPSE AFTER ANGIOGENIC METRONOMIC THERAPY IN HEPATOCELLULAR CARCINOMA XENOGRAFTS
… revealed that those cells had a hAFP+/CD13+/PCNA- phenotype, suggesting that they were dormant cancer stem cells (CSC). Indeed, off-therapy mice developed rapidly tumor growth, which was still sensitive to LDM-CTX therapy. The capacity of developing hepatoshperes in vitro was …
-
Platinum-NGR A Peptide Targeting Conjugate Of Cisplatin: Design, Synthesis, And Efficacy In Breast Cancer Cells
… interaction with aminopeptidase N (APN), or CD13, receptors. Fmoc solid phase chemistry was employed via a peptide synthesizer to produce mPeg-CNGRC-mal free peptide that was then cyclized and conjugated to activated cisplatin, producing a conjugated platinum-peptide complex specific to APN …
-
ANALYSIS OF DATA FROM A STUDY TO IDENTIFY POTENTIAL BIOMARKERS TO INDICATE RENAL INJURY
… KIM-1. Biomarkers of interest in this study are CD13, CD10, and CD26. Results from the linear mixed model, from the murine animal study, determined that these biomarkers express significantly higher concentrations in damaged tissue. Predictive modeling on the clinical data indicated that CD13 and …
-
Kininase I Mediated Signaling Evidenced in Hypertension and Target Organ Damage
… partners, such as CPM and aminopeptidase N (CD13), in the hypothalamic paraventricular nucleus (PVN) of WT and CPNKO mice. CPN activity assays revealed that overstimulation with Ang II in WT mice promoted CPN activity in plasma. Interestingly, Ang II infusions did not cause a significant …
-
Synthesis and Processing of Co-Axial/Tri-Axial Multi-Layered Nano-Particles
… combinations as core material with PCL and CD13-targeting peptide as the third layer: (1) Dextran core with GW2850 and PCL shells, and (2) GW2850 core encapsulated by PCL and NGR CD13-peptide. UV-Vis and FTIR analysis confirmed the presence of each drug component in the final particles, …
-
Differenzierungsabhängige Modulation der Zytokin- und Chemokinexpression bei humanen myeloischen Zell-Linien
… der Oberflächenmoleküle (CD7, CD11b, CD11c, CD13, CD14, CD15, CD18, CD19, CD33, CD34, CD38, CD40, CD41, CD42b, CD45, CD45RA, CD45RO, CD61, CD69, CD71, CD95, CD154, Glykophorin A, HLA-DR), der Zytochemie (Myeloperoxidase, Lysozym, unspezifische Esterase) und der Zellmorphologie untersucht. Es …
-
Η ΣΥΜΒΟΛΗ ΤΟΥ ΑΝΟΣΟΦΑΙΝΟΤΥΠΟΥ ΤΩΝ ΛΕΥΧΑΙΜΙΚΩΝ ΚΥΤΤΑΡΩΝ ΣΤΗΝ ΠΡΟΓΝΩΣΗ ΚΑΙ ΤΗΝ ΑΝΙΧΝΕΥΣΗ ΥΠΟΛΕΙΜΜΑΤΙΚΗΣ ΝΟΣΟΥ ΣΕ ΑΣΘΕΝΕΙΣ ΜΕ ΟΞΕΙΑ ΜΗ ΛΕΜΦΟΒΛΑΣΤΙΚΗ ΛΕΥΧΑΙΜΙΑ
… WERE STUDIED WITH THE ANTIBODIES CD34, CD33, CD13, CD15, CD14, CD7, CD2, CD5, CD4, CD8, CD10, CD19, CD41, CD71, CD38, CD56, IA, TDT AND THE COMBINATIONS CD34/CD33, CD34/CD13, CD33/CD15, CD33/CD14, CD33/CD7, CD33/CD10, CD33/CD19, CD33/CD41, CD33/CD71, CD3 /CD19, CD4/CD8, CD10/IA, CD34/CD2, …
-
Peptide Targeting of Platinum Anti-Cancer Drug and Synthesis of Water Soluble Monofunctional Pt(II) Complexes Useful for Biological Labeling
… and destruction of cancer cells that had CD13 receptors compared to untargeted carboplatin drug. The development of targeted chemotherapeutic has opened a new approach for efficient delivery of antitumor toxins with minimal exposure to normal cells. Several peptide sequences are known to …
-
CD34 Chimerism is a Strong Predictor of AML/MDS Relapse
… Chimerism among myeloid lineage cells (e.g. CD13/33+ cells) has been used to detect engraftment, but its relevance in early detection of relapse is limited. The clinical sensitivity and specificity of myeloid cell chimerism have been poor, and the lead time from a positive test to frank …
-
CANCER-DERIVED EXTRACELLULAR VESICLES FOR TARGETED DELIVERY OF EGFRVIII SIRNA TO NEOPLASTIC TISSUE, EVALUATION OF THE HOMING MECHANISM AND POTENTIAL THERAPEUTIC APPLICATIONS IN GLIOBLASTOMA.
… sani. Tra queste proteine, l'aminopeptidasi N (CD13) ha mostrato una maggiore espressione nelle EVs derivate da tumori, confermata mediante immunoblotting. Poiché il CD13 è una proteina potenzialmente coinvolta nell’elevata affinità di legame delle EVs tumorali ai componenti dell’ECM, come …
-
Vergleichende Analyse von Antigenexpressionsmustern kindlicher cALL-Blasten und gesunden B-Zellvorstufen – Nutzen für die MRD Diagnostik
… allem die Marker CD11b, CD38, CD58, CD123 und CD133, sowie die myeloischen Marker CD13 und CD33. Die Bessere Unterscheidung zwischen gesunden und kranken Zellen zusammen mit neuen Entwicklungen in Diagnostik und Therapie muss in Zukunft zur weiteren Verbesserung der Überlebensraten, auch im …
-
Einfluss der Zusammensetzung der myeloiden Zellpopulation auf die Expression alternativer proangiogener Faktoren durch Mikroglia/Makrophagen im humanen Glioblastom
… proangiogener Faktoren wie CXCL2 und CD13 im Vergleich zur Epilepsie , Astrozytom- und GBM-lPMNL-Gruppe gefunden werden. Die Granulozyten der GBM-hPMNL-Gruppe partizipierten über Produktion von IL-8 und CD13 an der Angiogenese. Zusätzlich zeigte sich in der GBM-hPMNL-Gruppe eine …
-
Μελέτη κυτταρικών πληθυσμών μυελοδυσπλαστικών και μυελοδυσπλαστικών/μυελοϋπερπλαστικών συνδρόμων με κυτταρομετρία ροής και μοριακές τεχνικές: επικύρωση μεθόδου και συσχέτιση με άλλες κλινικοεργαστηριακές παραμέτρους
… antibodies [CD3, CD4, CD5, CD7, CD10, CD11b, CD13, CD14, CD15, CD16, CD19, CD33, CD34, CD36, CD38, CD45, CD45RO, CD45RA, CD56, CD62L, CD64, CD79a, CD116, CD117, anti-HLA-DR, anti-KOR-SA, anti-MPO, anti-LF, anti-TCRγδ, 7AAD] in BM specimens of Controls (Ν=17) and patients with MDS (Ν=72), …
Page 1 of 3